Lake Oswego, Oregon--(Newsfile Corp. - December 22, 2025) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced the release of its Skin, Beauty & Anti-Aging Bundle by Kirkman®; a holistic solution designed to promote healthy, youthful skin by supporting detoxification, cellular renewal, and protection against environmental stressors. This carefully crafted bundle combines four powerful ingredients—Reduced Glutathione, Zinc Cream, Biotin, and Grap ...

Revenue Performance - Net revenue for the three months ended September 30, 2025, was $1,694,174, representing an increase of approximately 21% compared to $1,395,913 for the same period in 2024 [202]. - Net revenue for the nine months ended September 30, 2025, was $5,116,963, reflecting a 5% increase from $4,886,359 in the prior year [203]. Profitability Metrics - Gross profit margin for the three months ended September 30, 2025, improved to 57.7%, up from 54.7% in the same period of 2024 [206]. - Operating loss for the three months ended September 30, 2025, decreased to $(78,288), a 64% improvement from $(218,771) in the prior year [201]. Interest and Other Income - Interest expense for the three months ended September 30, 2025, increased by approximately 123% to $155,310, compared to $69,638 in the same period of 2024 [212]. - Other income for the three months ended September 30, 2025, surged to $492,599, primarily due to an Employee Retention Tax Credit reimbursement of $491,801 [214]. Cash Flow and Financing Activities - Net cash provided by operating activities for the nine months ended September 30, 2025, was $1,478,358, a significant increase of approximately 2,829% from $(54,178) in the prior year [218]. - Cash used in financing activities for the nine months ended September 30, 2025, was $676,164, representing an increase of approximately 891% from $68,206 in the same period of 2024 [220]. Debt and Obligations - The company owes $2,227,366 for the Kirkman acquisition as of September 30, 2025, with a forbearance agreement executed to postpone principal payments [216]. - On November 4, 2025, the company completed a private placement for gross proceeds of $8,000,000, netting approximately $7,360,000 after commissions [221]. - The Company executed a loan agreement for $150,000 with a 12.5% OID, totaling $171,500, and issued 37,500 warrants [223]. - A related party loan agreement was executed for $130,000 with a 20% annual interest rate, due March 11, 2031 [224]. - The Company entered a line of credit agreement for $300,000 with a 27% interest rate, settled in full on January 22, 2024 [224]. - An additional line of credit agreement was established for $100,000 with a 5% interest rate, settled in full on July 7, 2024 [225]. - A short-term debt facility was entered into for $247,634, which is non-interest-bearing and remains outstanding as of September 30, 2025 [226]. Inventory and Asset Management - As of September 30, 2025, the allowance for inventory obsolescence increased by $12,895, resulting in a reserve of $77,722 [228]. - The Company did not recognize impairment losses for long-lived assets during the nine months ended September 30, 2025, and 2024 [229]. Regulatory and Reporting Status - The Company adopted ASU 2023-07 effective December 31, 2024, requiring additional segment reporting disclosures [235]. - The Company is classified as an "emerging growth company" and a "smaller reporting company," with annual revenue less than $100 million [240][244]. - The Company may continue to rely on exemptions from certain disclosure requirements as a smaller reporting company [245].

Financial Performance - Revenue for Q3 2025 was $1.7 million, an increase of 21.4% compared to Q3 2024, driven primarily by growth in direct-to-consumer sales[8] - Gross profit rose by 28.1% year-over-year, with gross profit margin improving by 310 basis points to 57.8% due to higher revenue and better cost control[8] - Net income for Q3 2025 was $0.3 million, or $0.04 per diluted share, compared to a net loss of $0.3 million, or $(0.04) per diluted share in the prior year[8] - Net loss for the nine months ended September 30, 2025, was $93,837, compared to a net loss of $281,606 for the same period in 2024[18] - The company reported a significant other income of $491,801 from an ERTC refund, contributing to the positive net income for the quarter[15] Assets and Liabilities - Total current assets increased to $4.21 million as of September 30, 2025, up from $2.86 million at the end of 2024[13] - Total assets reached $8.23 million, compared to $7.17 million at the end of 2024, reflecting a strong financial position[13] - Total liabilities increased to $7.63 million as of September 30, 2025, compared to $7.29 million at the end of 2024[13] Cash Flow - Net cash provided by operating activities was $1,478,358, a significant increase from a cash used of $54,178 in the prior year[18] - Cash at the end of the period increased to $1,005,324, up from $250,170 at the end of the previous year[18] - Cash paid for interest amounted to $241,662, compared to $187,031 in the prior year[18] Strategic Initiatives - The company completed a direct listing on the Nasdaq Capital Market under the symbol MEHA, enhancing its capital foundation for expansion[4] - A strategic partnership with Market Performance Group was established to enhance the growth of the Kirkman brand across eCommerce and digital channels[5] - The P2i by Kirkman prenatal supplement became the first to comply with California's SB 646 QR-code disclosure law ahead of the January 2027 deadline[5] Accounts and Expenses - The company recorded an allowance for doubtful accounts receivable of $3,796, while the allowance for inventory obsolescence was $12,895[18] - Total accounts receivable increased by $218,054, contrasting with a decrease of $103,316 in the previous year[18] - The company incurred financing expenses on warrant issuance totaling $45,263[18] - Deferred offering costs were $667,810, significantly higher than $95,625 in the prior year[18] - Proceeds from loans were $195,277, down from $280,000 in the previous year[18] - The company issued common stock for convertible note payable and accrued interest amounting to $122,331[18]

Core Insights - Functional Brands Inc. reported strong financial growth in Q3 2025, with significant achievements that position the company for accelerated growth [2][3] - The company successfully completed its direct listing on the Nasdaq Capital Market under the symbol MEHA, which is seen as a validation of its business model and a foundation for future expansion [2] - The P2i by Kirkman prenatal supplement became the first to align with FIGO's transparency standards and comply with California's SB 646 QR-code disclosure law ahead of the 2027 deadline [3] Financial Performance - Revenue for Q3 2025 reached $1.7 million, marking a 21.4% increase compared to Q3 2024, driven primarily by growth in direct-to-consumer sales [8] - Gross profit increased by 28.1% year-over-year, with the gross profit margin improving by 310 basis points to 57.8% due to higher revenue and better cost control [8] - The company reported a net income of $0.3 million or $0.04 per diluted share, a turnaround from a net loss of $0.3 million in the prior year [8] Balance Sheet Highlights - As of September 30, 2025, total assets amounted to $8.23 billion, an increase from $7.17 billion at the end of 2024 [7] - Current assets rose to $4.21 billion, up from $2.86 billion at the end of 2024, with cash increasing significantly to $1.01 million [7] - Total liabilities increased to $7.63 billion from $7.29 billion, with current liabilities also rising to $5.70 billion [7] Strategic Initiatives - The company formed a partnership with Market Performance Group to enhance the growth of its Kirkman brand across eCommerce and digital channels [3] - Functional Brands is focused on acquiring and growing science-based consumer brands, with a commitment to providing high-quality wellness solutions [4]

Core Insights - Functional Brands Inc. has announced that its P2i™ by Kirkman® Prenatal Multivitamin & Multimineral is the first prenatal supplement globally to align with FIGO's transparency standards and comply with California's SB 646 QR-Code Disclosure Law [1][5] Group 1: Compliance and Standards - P2i™ by Kirkman® is the first prenatal supplement to align its testing and transparency practices with FIGO's position statement on toxic chemicals and environmental contaminants [1][4] - California's SB 646 is the first law in the U.S. requiring testing and public disclosure of toxic heavy metals in prenatal supplements, mandating a QR code on packaging that links to detailed test results [2][5] Group 2: Product Features and Transparency - P2i was designed to meet the urgent need for scientifically formulated prenatal nutrition that is transparently tested and documented [3] - The product undergoes comprehensive testing for 120 toxicants and 24 heavy metals, along with microbiological and allergen panels [8] - Each product box includes a QR code linking to the latest test results online, providing public lab reports that show measured levels for each tested element [8][9] Group 3: Company Overview - Functional Brands Inc. focuses on acquiring and growing science-based consumer brands, including Kirkman® and P2i by Kirkman®, and is committed to providing high-quality, effective health solutions [10]

Functional Brands Issues Letter to ShareholdersMaking Everyone Healthy Again: A Milestone Moment and Strategic Vision for GrowthNovember 24, 2025 8:00 AM EST | Source: Functional Brands Inc.Lake Oswego, Oregon--(Newsfile Corp. - November 24, 2025) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, issued the following letter from Eric Gripentrog, Chief Executive Officer.Dear Valued Shareholders,It is with great pride and enthusiasm that I write t ...

Group 1: BETA Technologies - BETA Technologies went public on November 4, raising $1.015 billion by issuing 29.85 million shares at an initial price of $34 per share [3] - On its first trading day, BETA's stock opened at $34, reached a high of $38.33, and closed at $36, marking a 5.88% increase and a total market capitalization of $7.88 billion [1] - The company specializes in the development of electric vertical takeoff and landing (eVTOL) aircraft, including related electric propulsion systems and charging solutions [4] Group 2: Functional Brands - Functional Brands listed on NASDAQ through a direct listing, offering over 150 health supplement products, including probiotics, vitamins, and amino acids [4] - For the first half of 2025, Functional Brands reported revenue of $342,000, a slight decrease from $349,000 in the same period the previous year, with a net loss of $35,000 compared to a profit of $700 [4] Group 3: SPACs - Cantor Equity Partners V (CEPV) and Westin Acquisition (WSTNU) are both special purpose acquisition companies (SPACs) that entered NASDAQ, raising $220 million and $50 million, respectively [4] - CEPV, based in New York, aims to target acquisitions in financial services, digital assets, healthcare, real estate services, technology, and software sectors [5] - Westin Acquisition, headquartered in Singapore, plans to focus on companies in the Asia-Pacific region with significant growth potential [5]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for comply with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐ As filed with the Securities and Exchange Commission on October 16, 2025. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 13 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FUNCTIONAL BRANDS INC. (form ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 12 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FUNCTIONAL BRANDS INC. (formerly HT Naturals Inc.) (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on October 1, 2025. Registration No. 333-284180 Delaware 325411 85-4094332 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) ( ...

company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. | Large accelerated filer | ☐ | Accelerated filer | ☐ | | --- | --- | --- | --- | | Non-accelerated filer | ☒ | Smaller reporting company | ☒ | | | | Emerging growth company | ☒ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for comply with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐ As f ...